Description
This blend is a research material intended for controlled laboratory settings where both constituents are used in combination. Typical use cases include growth hormone secretagogue receptor pharmacology, comparative GHRH-analog work, and non-clinical in vitro assay workflows.
Note that equal mass does not mean equal molar quantity: at 3367.9 versus 711.85 g/mol, a 5 mg/5 mg vial is roughly 1:4.7 in molar terms, favoring Ipamorelin by a wide margin. This matters when calculating receptor occupancy or designing dose–response work.
Documentation such as COA, HPLC chromatograms, and LC-MS data may be available on a lot basis where applicable. Request documentation by emailing connect@novuspeptides.com with the catalog number and required tests.
This product is sold strictly for laboratory research use only and is not intended for human or veterinary administration. Buyer is responsible for lawful handling, storage, and use in accordance with all applicable regulations.
Technical Summary
- Catalog #:CJC-1295/IPAMORELIN
- Form:Lyophilized Powder (5 mg / 5 mg)
- Purity:≥ 99%
- Verification:HPLC / LC-MS
- CAS Number:Mixture — see components
- Molecular Weight:Mixture — see components
- Molecular Formula:Mixture — see components
- Component 1 — CJC-1295 (No DAC):5 mg · CAS 863288-34-0 · C152H252N44O42 · 3367.9 g/mol · 29 aa
- Component 2 — Ipamorelin:5 mg · CAS 170851-70-4 · C38H49N9O5 · 711.85 g/mol · 5 aa (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
- Appearance:White Lyophilized Powder
